Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms

被引:345
作者
Biswas, Subhra K. [2 ]
Sica, Antonio [3 ]
Lewis, Claire E. [1 ]
机构
[1] Univ Sheffield, Sch Med, Tumor Targeting Grp, Acad Unit Pathol,Sir Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England
[2] Agcy Sci & Technol Res, Inst Biomed Sci, Singapore Immunol Network, Singapore, Singapore
[3] Ist Clin Humanitas, Milan, Italy
关键词
D O I
10.4049/jimmunol.180.4.2011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies have shown that macrophages play an,important part in both tumor initiation and various key steps in growth and metastasis. These cells show a remarkable degree of plasticity during tumor development with a cc switch" in macrophage phenotypes occurring during the course of tumor progression. During chronic inflammation they appear to predispose a given tissue to tumor initiation by the release of factors that promote neoplastic transformation. Following this, their phenotype shifts more toward one that is immunosuppressive and supports tumor growth, angiogenesis, and metastasis. In this review, we discuss the evidence for this plasticity of macrophage functions, the specific signaling mechanisms that may be regulating it, and the new targets for anticancer therapies highlighted by these findings.
引用
收藏
页码:2011 / 2017
页数:7
相关论文
共 61 条
  • [1] Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior
    Auffray, Cedric
    Fogg, Darin
    Garfa, Meriem
    Elain, Gaelle
    Join-Lambert, Olivier
    Kayal, Samer
    Sarnacki, Sabine
    Cumano, Ana
    Lauvau, Gregoire
    Geissmann, Frederic
    [J]. SCIENCE, 2007, 317 (5838) : 666 - 670
  • [2] Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    Balkwill, F
    Charles, KA
    Mantovani, A
    [J]. CANCER CELL, 2005, 7 (03) : 211 - 217
  • [3] Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells
    Banerjee, A
    Gugasyan, R
    McMahon, M
    Gerondakis, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (09) : 3274 - 3279
  • [4] Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages
    Barker, RN
    Erwig, LP
    Pearce, WP
    Devine, A
    Rees, AJ
    [J]. PATHOBIOLOGY, 1999, 67 (5-6) : 302 - 305
  • [5] A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation)
    Biswas, SK
    Gangi, L
    Paul, S
    Schioppa, T
    Saccani, A
    Sironi, M
    Bottazzi, B
    Doni, A
    Vincenzo, B
    Pasqualini, F
    Vago, L
    Nebuloni, M
    Mantovani, A
    Sica, A
    [J]. BLOOD, 2006, 107 (05) : 2112 - 2122
  • [6] Myeloid differentiation factor 88-independent Toll-like receptor pathway: Sustaining inflammation or promoting tolerance?
    Biswas, Subhra K.
    Tergaonkarl, Vinay
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (09) : 1582 - 1592
  • [7] Cutting edge: Involvement of the type IIFN production and signaling pathway in lipopolysaccharide-induced IL-10 production
    Chang, Elmer Y.
    Guo, Beichu
    Doyle, Sean E.
    Cheng, Genhong
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (11) : 6705 - 6709
  • [8] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867
  • [9] HIF-1α is essential for myeloid cell-mediated inflammation
    Cramer, T
    Yamanishi, Y
    Clausen, BE
    Förster, I
    Pawlinski, R
    Mackman, N
    Haase, VH
    Jaenisch, R
    Corr, M
    Nizet, V
    Firestein, GS
    Gerber, HP
    Ferrara, N
    Johnson, RS
    [J]. CELL, 2003, 112 (05) : 645 - 657
  • [10] Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
    De Palma, M
    Venneri, MA
    Galli, R
    Sergi, LS
    Politi, LS
    Sampaolesi, M
    Naldini, L
    [J]. CANCER CELL, 2005, 8 (03) : 211 - 226